Package 61755-018-01

{"route": ["INTRAVENOUS"], "spl_id": "03d5650a-82d9-4af5-9515-ea52c93733ef", "openfda": {"unii": ["UY9LQ8P6HW", "FJZ07Q63VY", "KOP95331M4"], "rxcui": ["2461536", "2461539", "2571682", "2571685"], "spl_set_id": ["0536b6fe-6fe5-4fd6-8cc6-1b481945c1fa"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-018-01)  / 14.5 mL in 1 VIAL, SINGLE-DOSE (61755-018-00)", "package_ndc": "61755-018-01", "marketing_start_date": "20201014"}], "brand_name": "Inmazeb", "product_id": "61755-018_03d5650a-82d9-4af5-9515-ea52c93733ef", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "61755-018", "generic_name": "atoltivimab, maftivimab, and odesivimab-ebgn", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Inmazeb", "active_ingredients": [{"name": "ATOLTIVIMAB", "strength": "241.7 mg/14.5mL"}, {"name": "MAFTIVIMAB", "strength": "241.7 mg/14.5mL"}, {"name": "ODESIVIMAB", "strength": "241.7 mg/14.5mL"}], "application_number": "BLA761169", "marketing_category": "BLA", "marketing_start_date": "20201014", "listing_expiration_date": "20261231"}